SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950123-10-064430
Filing Date
2010-07-08
Accepted
2010-07-08 17:29:33
Documents
1
Group Members
ARTISTRY ACQUISITION CORP.CELGENE CORPORATION

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D c03276sc13d.htm SC 13D 103672
  Complete submission text file 0000950123-10-064430.txt   105870
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filed by) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11755 WILSHIRE BLVD., 20TH FLOOR LOS ANGELES CA 90025
Business Address 11755 WILSHIRE BLVD., 20TH FLOOR LOS ANGELES CA 90025 310-883-1300
Abraxis BioScience, Inc. (Subject) CIK: 0001409012 (see all company filings)

IRS No.: 300431735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-83382 | Film No.: 10944925
SIC: 2834 Pharmaceutical Preparations